View PALB2 gene homepage

General information
Gene symbol PALB2
Gene name partner and localizer of BRCA2
Chromosome 16
Chromosomal band p12.2
Imprinted Unknown
Genomic reference LRG_308
Transcript reference NM_024675.3
Associated with diseases ?, MINAS, MRTES, polyposis, adenoma, cancer, cancer, brain, cancer, breast, cancer, rectal, lymphoma, neoplasia, colorectal, early onset, polyp
Citation reference(s) -
Curators (1) John Paul Plazzer
Total number of public variants reported 0
Unique public DNA variants reported 0
Individuals with public variants 0
Hidden variants 0
Date created September 21, 2016

Links to other resources
HGNC 26144
Entrez Gene 79728
PubMed articles PALB2
OMIM - Gene 610355
OMIM - Diseases MRTES (Muir-Torre Syndrome)
HGMD PALB2
GeneCards PALB2
GeneTests PALB2


Active transcripts


ID     

Chr     

Name     

NCBI ID     

NCBI Protein ID     

DescendingVariants     
00000013 16 partner and localizer of BRCA2 NM_024675.3 NP_078951.2 0


Copyright & disclaimer
The contents of this LOVD database are the intellectual property of the respective curator(s). Any unauthorised use, copying, storage or distribution of this material without written permission from the curator(s) will lead to copyright infringement with possible ensuing litigation. Copyright © 2016-2017. All Rights Reserved. For further details, refer to Directive 96/9/EC of the European Parliament and the Council of March 11 (1996) on the legal protection of databases.

We have used all reasonable efforts to ensure that the information displayed on these pages and contained in the databases is of high quality. We make no warranty, express or implied, as to its accuracy or that the information is fit for a particular purpose, and will not be held responsible for any consequences arising out of any inaccuracies or omissions. Individuals, organisations and companies which use this database do so on the understanding that no liability whatsoever either direct or indirect shall rest upon the curator(s) or any of their employees or agents for the effects of any product, process or method that may be produced or adopted by any part, notwithstanding that the formulation of such product, process or method may be based upon information here provided.